本頁面由Tiger Trade Technology Pte. Ltd.提供服務

奧麥羅製藥

17.87
-0.5800-3.14%
盤後17.890.0200+0.11%19:43 EDT
成交量:215.19萬
成交額:3,864.07萬
市值:12.93億
市盈率:11.37
高:18.69
開:18.69
低:17.68
收:18.45
52周最高:19.65
52周最低:4.05
股本:7,237.54萬
流通股本:6,825.80萬
量比:1.19
換手率:3.15%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
淨資產收益率:-576.33%
總資產收益率:-18.68%
市淨率:-25.19
市盈率(LYR):-338.79

資料載入中...

2021/05/20

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report